600587 新华医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.6106.9119.27410.2919.705
总资产报酬率 ROA (%)0.8403.4694.4454.5814.070
投入资产回报率 ROIC (%)1.1524.7916.1826.4125.634

边际利润分析
销售毛利率 (%)24.64525.14726.05626.48226.439
营业利润率 (%)6.5336.0697.9697.5616.312
息税前利润/营业总收入 (%)7.0766.3548.1317.5216.601
净利润/营业总收入 (%)5.5315.4256.9056.7575.677

收益指标分析
经营活动净收益/利润总额(%)108.588102.185100.077104.644104.088
价值变动净收益/利润总额(%)-15.9296.6158.90112.6801.106
营业外收支净额/利润总额(%)1.2640.043-0.359-2.488-1.691

偿债能力分析
流动比率 (X)1.4121.3581.2941.2611.069
速动比率 (X)0.9650.9150.8300.7870.631
资产负债率 (%)44.92946.30648.58750.48355.349
带息债务/全部投入资本 (%)25.66426.96530.23332.31939.797
股东权益/带息债务 (%)281.013263.116224.087202.896146.619
股东权益/负债合计 (%)117.717111.245100.70892.98875.148
利息保障倍数 (X)15.40622.48542.65052.27816.728

营运能力分析
应收账款周转天数 (天)77.52370.10064.20661.08463.546
存货周转天数 (天)150.863154.603167.911161.024140.631